UnitedHealth Group, the nation’s largest private health insurer, raised its 2026 earnings guidance to $19.50–$20.00 per share on July 16 after posting a second-quarter beat that far exceeded Wall Street expectations. The Minneapolis-based company raised its full-year outlook from prior guidance of more than $18.25 per share, reflecting stronger-than-anticipated performance across its business divisions.
The company reported second-quarter adjusted earnings per share of $6.38, a 56% increase from the year-earlier quarter and roughly 30% ahead of the $4.91 consensus forecast. Consolidated revenues for the quarter reached $112.0 billion, with operating earnings of $8.0 billion, according to UnitedHealth’s earnings announcement.
The earnings beat was driven primarily by improved medical cost management. UnitedHealth’s medical cost ratio—the percentage of premium revenue spent on members’ medical care—fell to 86.7% in the second quarter from 89.4% a year earlier, a 270-basis-point improvement. The ratio included $860 million in favorable prior-period development, according to company filings.
This cost-control performance proved critical to the guidance raise. The company now expects a full-year medical care ratio of 88.1% plus or minus 25 basis points, suggesting continued pressure on medical expenses but better management than initially anticipated. Benefit design improvements and operational efficiency gains contributed to the Q2 performance, allowing UnitedHealth to absorb rising healthcare costs while expanding margins.
UnitedHealth’s guidance raise is part of a broader trend among major U.S. health insurers. Other companies have raised guidance following strong second-quarter results, as insurers benefited from higher premiums and better-than-expected cost control. CVS Health raised its 2026 guidance following first-quarter results, while Centene lifted its full-year revenue guidance to between $193.5 billion and $197.5 billion in late July after reporting strong second-quarter growth, according to Wall Street Journal reporting.
The company’s stock rallied on the announcement, with UnitedHealth shares surging roughly 8% in morning trading on the guidance raise and strong Q2 results. The higher earnings outlook reflects management confidence that cost pressures—which had weighed on the company in 2025—are now under control, positioning UnitedHealth for sustained profitability in the second half of 2026.
Sources
- UnitedHealth Group — Q2 2026 earnings announcement and guidance raise to $19.50–$20.00 per share
- Reuters — Medical cost ratio improvement and earnings beat details
- CNBC — Guidance raise and prior outlook comparison
- Healthcare Dive — Guidance raise context and cost control analysis
- Wall Street Journal — Centene guidance raise and broader insurer performance
